Study of uncertain cystic fibrosis after newborn screening
Part of Genetic & congenital clinical trials.
This trial is for people whose newborn screening for cystic fibrosis left some uncertainty. It looks at those with an unclear sweat test or genetic findings that don't fully confirm CF, to better understand their health and needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a newborn screening that suggested possible cystic fibrosis (CF).
- Your sweat test result was in the 'intermediate' range (not clearly normal or high).
- Or, genetic testing found two changes in the CF gene, but at least one of them is not a known cause of CF.
- You do NOT have two CF-causing gene changes (that would mean you have CF).
- You have at least one gene change in the CF gene (not zero and not just one).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced diagnostic tests to help people whose cystic fibrosis (CF) diagnosis is unclear. It aims to give a clearer answer about whether you have CF or a related condition.
This study collects cells from people with cystic fibrosis (CF) caused by rare CFTR gene changes. The goal is to build a cell bank for future research, which may help scientists develop better tests and treatments for rare CF types.
This study looks for simple signals (markers) that may show whether cystic fibrosis treatments are working. It includes people who take CF “modulator” medicines like ivacaftor, people who don’t, and people whose cystic fibrosis was ruled out after testing.
This study enrolls newly diagnosed infants with cystic fibrosis to follow them during “precision medicine” care. It may help doctors better understand which treatments and monitoring work best, especially before certain infections develop.
This study is a registry that collects health information (and some lab samples) from Chinese children who may have cystic fibrosis (CF). It helps researchers better understand CF in children and how it is diagnosed.
This trial tests how well cystic fibrosis (CF) medicine works for you using an “n-of-1” approach, meaning you try treatments in a structured, repeated way to see what helps you most. It may help your care team choose the best option for your specific CF genetics and health status.
Hear when a new CFTR-RD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.